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Abstract 
Biosurfactants are unique secondary metabolites, synthesised non-ribosomally by certain bacteria, fungi and yeast, 
with their most promising applications as antimicrobial agents and surfactants in the medical and food industries. 
Naturally produced glycolipids and lipopeptides are found as a mixture of congeners, which increases their antimi-
crobial potency. Sensitive analysis techniques, such as liquid chromatography coupled to mass spectrometry, enable 
the fingerprinting of different biosurfactant congeners within a naturally produced crude extract. Bacillus amylolique-
faciens ST34 and Pseudomonas aeruginosa ST5, isolated from wastewater, were screened for biosurfactant production. 
Biosurfactant compounds were solvent extracted and characterised using ultra-performance liquid chromatography 
(UPLC) coupled to electrospray ionisation mass spectrometry (ESI–MS). Results indicated that B. amyloliquefaciens 
ST34 produced C13–16 surfactin analogues and their identity were confirmed by high resolution ESI–MS and UPLC–
MS. In the crude extract obtained from P. aeruginosa ST5, high resolution ESI–MS linked to UPLC–MS confirmed the 
presence of di- and monorhamnolipid congeners, specifically Rha–Rha–C10–C10 and Rha–C10–C10, Rha–Rha–C8–C10/
Rha–Rha–C10–C8 and Rha–C8–C10/Rha–C10–C8, as well as Rha–Rha–C12–C10/Rha–Rha–C10–C12 and Rha–C12–C10/Rha–
C10–C12. The crude surfactin and rhamnolipid extracts also retained pronounced antimicrobial activity against a broad 
spectrum of opportunistic and pathogenic microorganisms, including antibiotic resistant Staphylococcus aureus and 
Escherichia coli strains and the pathogenic yeast Candida albicans. In addition, the rapid solvent extraction combined 
with UPLC–MS of the crude samples is a simple and powerful technique to provide fast, sensitive and highly specific 
data on the characterisation of biosurfactant compounds.
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Introduction
Biosurfactants are secondary metabolites that are non-
ribosomally synthesised by actively growing and/or 
resting microbial cells (bacteria, fungi and yeast) (Van 
Delden and Iglewski 1998; Ron and Rosenberg 2001; 
Mulligan 2005). They have been classified into different 
groups based on their chemical composition and micro-
bial origin and they are divided into five major classes 
which include glycolipids, lipopeptides, phospholip-
ids, polymeric compounds and neutral lipids (Ron and 
Rosenberg 2001; Sen 2010). While they have been exten-
sively applied in bioremediation, industrial emulsification 
and enhanced oil recovery (Banat et  al. 2014), certain 
biosurfactant compounds have also been reported to 
display multipurpose biomedical and therapeutic prop-
erties, which include applications as antiadhesives, 
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anticarcinogens and antimicrobials (Benincasa et  al. 
2004; Mulligan 2005; Rodrigues et  al. 2006; Mulligan 
et al. 2014).
Glycolipids and lipopeptides constitute the most 
widely studied groups of biosurfactant compounds dis-
playing broad spectrum antimicrobial activity and are 
currently applied in several fields (cosmetic, food and 
pharmaceutical industries) as antimicrobial, emulsify-
ing and surfactant agents (Mandal et  al. 2013). The gly-
colipid based biosurfactants include mannosylerythritol 
lipids, sophorolipids, trehalolipids and the most domi-
nant group rhamnolipids, that are primarily produced by 
Pseudomonas species, particularly P. aeruginosa strains. 
Rhamnolipids consist of one or two rhamnose residues 
in their hydrophilic moiety linked to one, two or three 
hydroxyl fatty acid chains of varying lengths (eight to 22 
carbons) (Déziel et al. 1999; Gunther et al. 2005).
The lipopeptides generally contain similar peptide 
chains (short linear or cyclic structures). The hydrophilic 
moiety is composed of amino acid residues varying only 
at specific residues and is linked to varying lengths (satu-
rated and unsaturated) of fatty acids that act as the hydro-
phobic moiety (Makovitzki et al. 2006; Raaijmakers et al. 
2010; Yao et  al. 2012; Mandal et  al. 2013). Lipopeptides 
are widely produced by Bacillus species and they consist 
of bacillomycins, fengycins, iturins, mycosubtilins as well 
as the widely studied lipopeptide, surfactin (Ongena and 
Jacques 2008; Raaijmakers et  al. 2010; Sansinenea and 
Ortiz 2011; Chen et  al. 2015; Inès and Dhouha 2015). 
Surfactin is a cyclic heptapeptide consisting of hydro-
phobic and negatively charged amino acids with a chiral 
sequence LLDLLDL linked to hydroxyl fatty acyl residue 
of between 12 and 16 carbon atoms (Seydlová and Svo-
bodová 2008).
Several isoforms and analogues exist for the naturally 
produced glycolipids and lipopeptides, which is why 
they exhibit significant structural heterogeneity (Beni-
ncasa et  al. 2004; Ongena and Jacques 2008). A variety 
of methods are utilised to classify and characterise the 
biosurfactant compounds produced by a range of micro-
organisms. Mass spectrometry (MS) coupled with vari-
ous chromatographic methods are the most widely used 
techniques, where liquid chromatography (LC) coupled 
to electrospray ionisation mass spectrometry (ESI–MS) 
and matrix-assisted laser desorption ionisation time-
of-flight mass spectrometry (MALDI–TOF–MS) have 
shown a high sensitivity and accuracy in various analyses. 
MALDI–TOF–MS analysis enables the rapid fingerprint-
ing of low concentrations of metabolites directly from 
actively growing/resting microbial cells (Bright et  al. 
2002; Singhal et al. 2015), while the LC–ESI–MS requires 
growth of the microbial cells first and extraction of the 
compounds of interest before analysis. However, the 
LC–ESI–MS has been shown to be an enhanced method 
for the separation of different isoforms of the same ana-
logues and homologues within a crude extract (in super-
natant) produced using natural sources (Yang et al. 2015). 
Additionally, LC–ESI–MS is a powerful tool to utilise 
for quantitatively analysing complex compounds such as 
biosurfactants and can efficiently discriminate between 
different analogues and isoforms within a mixture of 
compounds.
Biosurfactant congeners display different physico–
chemical properties in combination, which can differ 
from the physico-chemical properties observed in indi-
vidual congeners (Bonmatin et  al. 2003). A study con-
ducted by Kracht et  al. (1999) indicated that surfactin 
molecules (produced by Bacillus subtilis OKB 105) with 
13 carbon atoms in their hydrophobic moiety exhibited 
low antiviral activity, while the surfactin isoform with 
15 carbon atoms displayed the highest antiviral activ-
ity. In addition, the presence of a single negative charge 
also contributed to an increased antiviral activity. Stud-
ies have indicated that the microbial strains utilised for 
glycolipid or lipopeptide production have an influence on 
the yield and composition of the compounds synthesised, 
which in turn has an effect on their antimicrobial activity 
(Déziel et al. 1999; HoŠková et al. 2013).
The antimicrobial property of biosurfactants rely on 
different mechanisms to destroy target organisms as 
compared to conventional antibiotics (Banat et al. 2010) 
and they primarily destroy bacterial cells by directly dis-
rupting the integrity of the plasma membrane or cell wall 
(Sang and Blecha 2008; Yount and Yeaman 2013). Most 
of the glycolipid and lipopeptide based biosurfactant 
compounds displaying antimicrobial properties, were 
extracted from microorganisms isolated from marine, 
terrestrial and sites contaminated by hydrocarbon based 
compounds (Abalos et al. 2001; Das et al. 2008; Sharma 
et al. 2014; 2015). Currently there is limited research on 
biosurfactant compounds produced by bacterial strains 
isolated from wastewater.
The current study focused on the purification and 
characterisation of antimicrobial glycolipid and lipopep-
tide biosurfactant compounds respectively, produced 
by Pseudomonas aeruginosa (P. aeruginosa) ST5 and 
Bacillus amyloliquefaciens (B. amyloliquefaciens) ST34 
strains that were isolated from a local wastewater treat-
ment plant. This aim was achieved by obtaining crude 
biosurfactant compounds from the B. amyloliquefa-
ciens ST34 and P. aeruginosa ST5 strains grown on min-
eral salt medium (supplemented with glycerol) as well 
as nutrient agar, using acid-precipitation followed by a 
rapid solvent extraction method. An ESI–MS coupled 
with ultraperformance liquid chromatography (UPLC) 
method, denoted UPLC–MS, was developed for the 
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characterisation of the biosurfactant extracts by using 
commercially available lipopeptides and glycolipids as 
standards. Finally, various opportunistic, pathogenic 
and antibiotic resistant bacteria and fungal strains were 
utilised for the assessment of the antimicrobial activ-
ity of the crude biosurfactant extracts obtained from the 
respective isolates.
Materials and methods
Bacterial isolates, media composition and biosurfactant 
production conditions
Biosurfactant producing bacteria were isolated from 
wastewater samples collected from Stellenbosch waste-
water treatment plant in the Western Cape, South Africa 
(GPS co-ordinates: −33.943505, 18.824584) as described 
by Ndlovu et al. (2016). The bacterial isolates ST34, iden-
tified as B. amyloliquefaciens (collection number SARCC 
696 at the South African Rhizobium Culture Collection) 
and ST5, identified as P. aeruginosa (collection number 
SARCC 697 at the South African Rhizobium Culture 
Collection), using molecular characterisation (Ndlovu 
et  al. 2016), were utilised in the current study for bio-
surfactant production. Henceforth the B. amylolique-
faciens and P. aeruginosa isolates will be referred to by 
their code identifiers, ST34 and ST5, respectively. The 
bacterial cultures were maintained in 40% glycerol at 
−80  °C. An inoculum of the glycerol stock of ST34 and 
ST5 was streaked onto a nutrient agar (NA) plate which 
was incubated for 18–24 h at 37 °C. A single colony from 
each respective NA culture was then used to inoculate 
5  mL sterile mineral salt medium (MSM) to prepare 
seed cultures. The MSM utilised for biosurfactant pro-
duction was composed of the following: 0.1% KH2PO4, 
0.1% K2HPO4, 0.02% MgSO4·7H2O, 0.002% CaCl2·2H2O, 
0.005% FeCl3·6H2O and 0.2% NaNO3 and 3% glycerol as 
the main carbon and energy source, with the pH of the 
medium adjusted to 6.8 (Silva et al. 2010). The cultivation 
conditions for preparation of the seed culture were 30 °C, 
at 200  rpm with an incubation time of 18–24  h. After 
seed culture preparation, a 2% cell suspension of 0.7 
optical density (OD) at 600 nm, which corresponded to 
approximately 107 colony forming units (CFU) mL−1, was 
inoculated into 500 mL baffled flasks containing 100 mL 
MSM. The broth cultures were incubated on a 200 rpm 
orbital shaker (MRCLAB, London, UK) for 120  h at 
30 °C.
Extraction and partial purification of the biosurfactants
The crude biosurfactant compounds produced by ST34 
and ST5 were obtained from the culture supernatant by 
a combination of acid and solvent extraction methods. 
Briefly, after 5 days of culturing the isolates in glycerol-
MSM, the culture (100 mL) was centrifuged at 11,305×g 
for 30 min at 4 °C to remove microbial cells. The presence 
of surface active compounds in the supernatant was then 
verified using the oil spreading method as previously 
described by Ndlovu et al. (2016). Thereafter the super-
natants were acidified to a pH of approximately 2 using 
hydrochloric acid (HCl, Merck, Darmstadt, Germany) as 
previously described by Das et al. (2008) and were stored 
overnight at 4 °C in order to precipitate the biosurfactant 
compounds. The precipitate was then harvested by cen-
trifugation at 11,305×g for 30 min at 4  °C, and the pel-
let was washed with 50  mL of analytical quality water 
(prepared through a MilliQ system from Millipore, Bill-
erica, USA), with the pH adjusted to 7.5 (Das et al. 2008). 
The respective insoluble fraction was then lyophilised 
and dissolved in 15% (v/v) methanol (Merck, Darm-
stadt, Germany) (crude extracts obtained from ST34 and 
ST5), transferred into analytically weighed sterile vials 
and lyophilised again. The extracts (ST34 and ST5) were 
analytically weighed and dissolved in 15% methanol to 
obtain a 1.00 mg mL−1 concentration, which was used for 
the characterisation and antimicrobial analysis (see list 
of test microbial strains in Tables 1 and 2). The methanol 
soluble fractions were lyophilised, further extracted using 
70% acetonitrile and then lyophilised again. The extracts 
(ST34 and ST5) were analytically weighed and dissolved 
in 15% acetonitrile to obtain a 1.00 mg mL−1 concentra-
tion for analysis using the UPLC–MS.
The ST34 and ST5 isolates were also cultured in 
duplicate on NA plates and NA slants (10  mL test 
tube) for approximately 5 days at 30  °C. Five millilitres 
of 70% acetonitrile (Romil, Cambridge, UK) was added 
to the NA plate cultures, which were then placed on a 
Bio dancer shaker (New Brunswick Scientific, Enfield, 
USA) at a speed of 5 rpm for approximately 5 min. The 
acetonitrile mixture was decanted into a sterile McCa-
rtney bottle. For the NA slant cultures, 5  mL of 70% 
acetonitrile was added to the test tube, the culture was 
vortexed for approximately 2 min, where after the ace-
tonitrile mixture was decanted into a sterile McCartney 
bottle. The lyophilised acetonitrile extracts obtained 
from NA plates and slants were then suspended in 1 mL 
sterile analytical quality water, the soluble supernatant 
was removed and the insoluble fractions were lyoph-
ilised and weighed analytically. After weighing, the 
extracts were dissolved in 15% acetonitrile to obtain a 
1.00  mg  mL−1 concentration, which was used for the 
characterisation of the biosurfactants produced by each 
bacterial strain.
Analysis with ultra‑performance liquid chromatography 
linked to electrospray ionisation mass spectrometry
Mass spectrometry analyses were performed in the 
LCMS Central Analytical Facility at the Stellenbosch 
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University. A Waters Quadrupole Time-of-Flight Synapt 
G2 (Waters Corporation, Miliford, USA) mass spectrom-
eter was utilised for the ESI–MS and was coupled to an 
Acquity UPLC for the UPLC–MS analysis of the biosur-
factant extracts. Three microlitres of the standards and 
acetonitrile soluble extracts (glycerol-MSM) obtained 
from ST34 and ST5 at 1.00  mg  mL−1 were directly 
injected into a Z spray electrospray ionisation source for 
direct mass analysis. The identities of the biosurfactant 
compounds were confirmed with high resolution MS by 
comparing it with the mass/charge ratio (m/z) obtained 
for bacillomycin, fengycin and mycosubtilin (LipoFab-
rik, Lille, France) and iturin A, surfactin and rhamnolipid 
(Sigma-Aldrich, St. Louis, USA) as standards.
For UPLC–MS analysis 3 µL of each standard, extracts 
obtained from glycerol-MSM liquid culture, NA sur-
face culture in a petri-dish and NA slant cultures in 
test tubes was injected and separated on an UPLC C18 
Table 1 Antibacterial activity of the biosurfactant extracts (1.00 mg mL−1) against a panel of Gram-negative and Gram-
positive bacterial isolates
The surfactin and rhamnolipid extracts were observed to be at 32.8 and 34.4% purity, respectively
Values are the means ± standard deviations (SD) of triplicate measurements; ATCC American Type Culture, O resistant to Oxacillin, G resistant to Gentamicin, T resistant 
to Tetracycline, P resistant to Penicillin G
Organism (strain number) Source Antibacterial inhibition zone diameter (mm) ± SD
Surfactin extract
(0.26 ± 0.09 mg mL−1)
Rhamnolipid extract
(1.12 ± 0.08 mg mL−1)
Gram-negative target organism
 Escherichia coli (ATCC 417373) ATCC 13 ± 0 13.5 ± 0.4
 E. coli (ATCC 13706) ATCC 10 ± 0 29.3 ± 0.9
 Enteroinvasive E. coli (ATCC 43892) ATCC 15 ± 0 22.7 ± 2.1
 GEnteropathogenic E. coli (B170) ATCC 18.3 ± 0.5 20.3 ± 0.5
 Enterohaemorhagic E. coli (O157:H7) ATCC 13.7 ± 0.5 13.7 ± 0.5
 Enterotoxigenic E. coli (H10407) ATCC 17.7 ± 1.2 13 ± 0
 Enteroaggregative E. coli (3591-87) ATCC 12.3 ± 0.5 24.3 ± 1.2
 Klebsiella pneumoniae (ATCC 10031) ATCC 14 ± 1.6 13.5 ± 0.5
 Salmonella typhimurium (ATCC 14028) ATCC 25.3 ± 1.2 20.3 ± 0.5
 Serratia marcescens (ATCC 13880) ATCC 12.7 ± 0.9 14 ± 0
 K. pneumoniae (P2) Clinical 13 ± 0.8 11.7 ± 0.9
 K. pneumoniae (P3) Clinical 13.3 ± 0.2 8.3 ± 0.5
 Salmonella enterica (SE19) Environment 12.5 ± 0.5 14 ± 0
 Acinetobacter sp. (F1S6) Environment 12.3 ± 0.5 13 ± 1.4
 Serratia sp. (SM14) Environment 11.7 ± 0.9 14.3 ± 1.2
 Serratia sp. (L8) Environment 12.5 ± 0.5 9.8 ± 0.8
 Enterobacter sp. (E11) Environment 11.3 ± 0.5 13 ± 0.8
 Enterobacter sp. (E22) Environment 14.2 ± 0.6 13 ± 0.8
 E. coli (K4CCA) Environment 14.5 ± 0.5 17.7 ± 1.9
 K. pneumoniae (k2a) Environment 15.3 ± 0.5 13.7 ± 0.5
Gram-positive target organism
 OStaphylococcus aureus (ATCC 25923) ATCC 14.7 ± 0.5 13.7 ± 0.5
 B. cereus (ATCC 10876) ATCC 10.3 ± 0.5 13 ± 0.8
 B. cereus (LMG 13569) ATCC 13 ± 0.8 17 ± 1.4
 Enterococcus faecalis (S1) Clinical 18.7 ± 0.9 10.7 ± 0.5
 Enterococcus faecalis (S2) Clinical 18.3 ± 1.2 21.7 ± 2.4
 G,O,P,TMRSA (Xen 30) Clinical 15.3 ± 0.5 13.3 ± 0.5
 Bacillus cereus (ST18) Environment Inactive 22.3 ± 0.9
 Enterococcus sp. (C513) Environment 12.3 ± 0.5 15.7 ± 0.5
 Micrococcus sp. (AQ4S2) Environment 14 ± 0 14 ± 1
 S. aureus (C2) Environment 11.5 ± 0.5 14 ± 0
 S. aureus (C3) Environment 12 ± 0 11 ± 0
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reverse-phase analytical column (Acquity UPLC® HSS 
T3, 1.8  µm particle size, 2.1 ×  150  mm, Waters corpo-
ration, Dublin, Ireland) at a flow rate of 0.300 mL min−1 
using a 0.1% formic acid (A) to acetonitrile (B) gradient 
(60% A from 0 to 0.5 min for loading, gradient was from 
40 to 95% B from 0.5 to 11  min and then 95 to 40% B 
from 15 to 18 min). The UPLC–MS profiles of the biosur-
factant compounds were compared to those obtained for 
bacillomycin, fengycin, iturin A, surfactin, rhamnolipid 
and mycosubtilin standards. Moreover, the concentra-
tion of surfactin and rhamnolipid in the extracts obtained 
from B.  amyloliquefaciens ST34 and P. aeruginosa 
ST5 strains were analysed using a UPLC–MS method 
described by Ndlovu (2017).
For both direct ESI–MS and UPLC–MS analyses, the 
analytes were subjected to a capillary voltage of 3  kV, 
cone voltage of 15 V and a source temperature of 120 °C. 
Data acquisition in the positive mode was performed by 
MS scanning a second analyser through the m/z range of 
200–3000 Da and the data was thereafter analysed using 
Masslynx software version 4.1 (Waters Corporation, Mil-
ford, USA).
Determination of antimicrobial activity: agar disc 
susceptibility test
The antimicrobial activity of the extracts obtained from 
ST34 and ST5, was analysed against various actively 
growing target reference strains [from American Type 
Culture Collection (ATCC)], environmental and clini-
cal Gram-positive and Gram-negative microbial strains 
(Table  1) as well as fungal strains (Table  2) on Muel-
ler Hinton agar (MHA) (Merck, Darmstadt, Germany). 
The bacterial environmental strains were isolated by our 
research group from rainwater tanks and surface water 
(Plankenburg River, Stellenbosch, South Africa), while 
the clinical strains were obtained from laboratories in 
the Department of Microbiology at Stellenbosch Uni-
versity (Stellenbosch, South Africa). Fungal strains iso-
lated from surface water (Benadé et al. 2016) and clinical 
samples obtained from the Environmental Biotechnol-
ogy laboratory in the Department of Microbiology (Stel-
lenbosch University, South Africa) were also included as 
antimicrobial test strains against ST34 and ST5 extracts. 
Briefly, the crude biosurfactant extracts were dissolved 
in 15% (v/v) methanol (70% acetonitrile was also utilised 
for the antimicrobial assays; results were however com-
parable or lower than the results obtained for the crude 
extract) and were filtered through a 0.22 µm low protein 
binding non-pyrogenic syringe filter (Pall Life Sciences, 
Ann Arbor, USA). A 100 µL overnight culture of the test 
microbial isolates (Tables 1, 2), which had been grown in 
Luria–Bertani broth (Merck, Darmstadt, Germany), was 
then spread plated onto the MHA to create a microbial 
lawn. Thereafter, using sterile tweezers, 6 mm filter paper 
discs (Oxoid, Basingstoke, UK) were placed onto the lawn 
and 50 µL of the biosurfactant extract (1.00  mg  mL−1), 
obtained from either ST34 or ST5, was pipetted directly 
onto the filter paper in order to create an antimicrobial 
disc. The antimicrobial tests were performed with a nega-
tive control (MHA plus test bacterial strain) and three 
positive controls [MHA plus pure surfactin and rham-
nolipid purchased from Sigma, USA, against the repre-
sentative Gram-positive Staphylococcus aureus ATCC 
25,923, the representative Gram-negative Escherichia coli 
ATCC 13,706 and the fungal isolate Cryptococcus neofor-
mans CAB1055]. All tests were performed in triplicate. 
All the MHA plates were then incubated at 37  °C for 
24–48 h where after the diameter of the zone of inhibi-
tion around the inoculated paper disc was measured (Das 
et al. 2008).
Statistical analysis
The diameters of the zones of inhibition produced by the 
ST34 and ST5 extracts against various microbial strains 
analysed in the current study, were expressed as mean 
values ± standard deviation. The student’s t test was then 
Table 2 In vitro antifungal activity of  the surfactin 
and  rhamnolipid biosurfactant extracts (1.00  mg  mL−1) 
against  a panel of  clinical and  environmental fungal iso-
lates as determined by agar disc diffusion method
The surfactin and rhamnolipid extracts were observed to be at 32.8 and 34.4% 
purity, respectively
a  Clinical strain
b  Environmental strain
Organism Antifungal zone diameter (mm)
Surfactin extract
(0.26 ± 0.09 mg mL−1)
Rhamnolipid extract
(1.12 ± 0.08 mg mL−1)
aCryptococcus neo-
formans CAB1063
Inactive 13 ± 0.8
aCryptococcus neo-
formans CAB1067
11.7 ± 0.5 14.3 ± 3.3
aCryptococcus neo-
formans CAB1055
15.3 ± 0.5 11.3 ± 0.9
aCandida albicans 
8911
13.3 ± 0.5 14.7 ± 0.5
aCandida albicans 
8912
13.3 ± 0.5 11.7 ± 0.5
bCryptococcus neo-
formans CAB1034
Inactive 18.3 ± 0.8
bCryptococcus neo-
formans CAB831
11.7 ± 1.7 15.3 ± 1.9
bCryptococcus neo-
formans CAB842
12.3 ± 0.9 Inactive
bCryptococcus neo-
formans CAB844
15.3 ± 1.2 16.7 ± 1.7
bCandida albicans 
1085
Inactive 14 ± 0.8
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utilised to determine the statistical significant difference 
between the diameters of the zones of inhibition between 
the extracts produced by ST34 and ST5, respectively, 
against the test bacterial and fungal strains. The P values 
of less than 0.05 (p < 0.05) were considered significant.
Results
Direct ESI–MS analysis for solvent extracted biosurfactant 
compounds produced by ST34
Solvent extracts of the glycerol-MSM liquid culture 
obtained from ST34 were subjected to direct infusion 
using positive mode ESI–MS in order to determine the 
accurate molecular mass (compound identity) for the 
solvent extracted biosurfactant compounds. The spec-
tra of the possible biosurfactant compounds produced 
by ST34 were compared to the surfactin, mycosubtilin, 
bacitracin, iturin A and fengycin standards. However, 
the compounds detected only corresponded to the pro-
file observed for the surfactin standard, hence only the 
results for surfactin standard are depicted in Fig.  1. In 
the ESI–MS spectrum of the ST34 extract from glyc-
erol-MSM, a cluster of m/z peaks with a difference of 
approximately 14 or 22 or 28 atomic mass units (amu) 
in their molecular ion species were detected, revealing 
Fig. 1 ESI–MS analysis of the ST34 glycerol-MSM extract (a) and surfactin standard (b). The positive mass spectrum generated with MaxEnt 3 is 
shown. The indicated masses are [Mr+H] = m/z values of singly charged species. Refer to Table 3 for identities of Srf1-5 and expected m/z and Mr 
values
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five groups of analogue molecules (Fig.  1). The spectra 
in positive mode showed the main groups of molecular 
ions at m/z 994.65, 1008.66, 1022.68, and 1036.69 which 
corresponded to the protonated singly charged species 
[M+  H]+ (Fig.  1; Table  3). Their corresponding sodium 
adducts [M+Na]+ were also detected at m/z 1016.63, 
1030.64, 1044.65 and 1058.66 (Fig.  1a; Table  3). For the 
standard surfactin, the spectra in the positive mode dis-
played the main groups of molecular ions at m/z 1008.66, 
1022.68 and 1036.66 which corresponded to the proto-
nated singly charged species [M+H]+ (Fig. 1c; Table 3). 
Their sodium adducts [M+Na]+ were also detected at 
m/z 1044.66 and 1058.68.
The singly charged protonated molecular species 
[M+H]+ at m/z 994.65, 1008.66, 1022.68 and 1036.66 
and their corresponding singly charged sodiated mol-
ecules [M+Na]+ (1016.6, 1030.6, 1044.66 and 1058.68) 
all differed by 14 or 28 amu (Table 3). The detected high 
resolution Mr values (ppm  <  10) of the possible surfac-
tin analogues in the ST34 extract corresponded to that 
of the C13, C14, C15 and C16 surfactin analogues (Srf1-5) 
in a standard surfactin, confirming their identity (Fig. 1; 
Table 3).
ESI–MS and UPLC–MS analysis of solvent extracted 
biosurfactant compounds produced by ST34
An optimised UPLC–MS method was employed to ana-
lyse the lipopeptide biosurfactant extract obtained from 
ST34 cultured in glycerol-MSM (ST34LC) is shown in 
Fig.  2b (compared with the surfactin standard; Fig.  2a). 
The UPLC–MS profiles of the biosurfactant compounds 
produced by ST34 corresponded very well with the pro-
file observed for the surfactin standard (Fig. 2a). Surface 
culture on NA (ST34NA) in test tubes (ST34NA-TSC) 
and petri dishes (ST34NA-PDC) were also utilised to 
produce biosurfactants by ST34, in order to increase 
the probability of detecting lipopeptides in/on differ-
ent growth media. As the NA cultures were extracted 
with 70% acetonitrile in water (v/v), the ST34LC (origi-
nal crude extract) was further extracted with 70% ace-
tonitrile (ST34LC-AE) and analysed. The comparative 
UPLC–MS profiles of the extracts are shown in Fig.  2. 
The UPLC–MS profiles of the surfactin standard and the 
extracts produced by ST34 showed significant peaks at 
retention times between 10 and 13 min.
From basic reverse-phase chromatography principles, 
it is expected that the surfactin species with the longer 
Table 3 Summary of  the detected surfactin lipopeptides extracted from  cultures of  B. amyloliquefaciens ST34, 
as detected using high resolution mass spectrometry (<10 ppm)
Surfactin  
group (Abbr)
UPLC Rt  
(min)a
Characterised and proposed* peptide  
sequences in surfactin group
Mono‑isotopic 
Exp/Theor Mr
Protonated 
specie Exp/
Theor m/z
Sodiated 
specie Exp/
Theor m/z
Surfactin 1 (Srf1) 10.6; 11.2 Cyclo[(C13H24O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Val]
Cyclo[(C13H24O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Val]
993.6376
993.6403
994.6472
994.6481
1016.6265
1016.6190
Surfactin 2 (Srf2) 11.0; 11.2; 11.9 Cyclo[(C14H26O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Val]
Cyclo[(C14H26O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Val]
1007.6521
1007.6552
1008.6604
1008.6596
1030.6350
1030.6328
Cyclo-[(C13H24O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
Cyclo[(C13H24O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
*Cyclo-[(C13H24O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
*Cyclo-[(C13H24O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
Surfactin 3 (Srf3) 11.6; 11.7; 12.3 Cyclo[(C15H28O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Val]
Cyclo[(C15H28O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Val]
1021.6693
1021.6715
1022.6780
1022.6752
1044.6586
1044.6494
Cyclo[(C14H26O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
Cyclo[(C14H26O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
*Cyclo-[(C14H26O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
*Cyclo-[(C14H26O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
Surfactin 4 (Srf4) 12.1; 12.2 Cyclo[(C15H28O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
Cyclo[(C15H28O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
*Cyclo[(C15H28O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
Cyclo[(C15H28O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
1035.6819
1035.6881
1036.6902
1036.6909
1058.6718
1058.6662
Surfactin 5 (Srf5) 12.6; 12.7 Cyclo[(C16H30O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
*Cyclo[(C16H30O2)-L-Glu-L-Leu-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
*Cyclo[(C16H30O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Leu]
*Cyclo[(C16H30O2)-L-Glu-L-Ile-D-Leu-L-Val-L-Asp-L-Leu-L-Ile]
1049.6992
1049.7032
1050.7120
1050.7066
1072.6926
1072.6886
Their proposed chemical structures, theoretical (Theor) and experimental (Exp) Mr and monoisotopic m/z values, as well as observed UPLC retention times for 
representative examples are provided
a  UPLC retention time of main peaks corresponding to the group’s m/z value
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fatty acyl chains will elute at a later retention time (Rt) 
from the C18 matrix. This was indeed the case, with the 
sequence of surfactin groups eluted as follows, surfactin 
1 (Srf1) (Rt 10.6; 11.2 min), Srf2 (Rt 11.0, 11.2, 11.9 min), 
Srf3 (Rt 11.6, 11.7, 12.3 min), Srf4 (Rt 12.1, 12.2 min) and 
Srf5 (Rt 12.6, 12.7 min) (Fig. 2; Table 3). In the surfactin 
groups, Ile/Leu analogues will elute closer or together, 
while the slightly smaller and less hydrophobic Val ana-
logues will elute earlier. It should be noted that the pep-
tide identities within specific surfactin groups were not 
fully explored as it was beyond the scope of the study. 
However, this UPLC–MS methodology has the potential 
to be extended to include tandem mass spectrometry and 
ion mobility on the Synapt G2 in future studies.
For the glycerol-MSM culture extracts, five peaks/peak 
clusters were observed on the UPLC–MS profile which 
corresponded to five surfactin groups. The five surfactin 
groups (Srf1, Srf2, Srf3, Srf4 and Srf5) exhibited similar 
retention times as the surfactin standard (Fig.  2b). As 
indicated, the ST34 was also cultivated in NA in order to 
increase the probability of detecting the produced bio-
surfactant compounds. The extracted UPLC–MS profiles 
for the NA extracts showed major peaks which corre-
sponded to Srf2, Srf3 and Srf4, while traces of Srf1 and 
Srf5 surfactin analogues were also detected (Fig. 2c).
A detailed analysis of some of the major peaks in the 
UPLC–MS profiles of the ST34LC extract (glycerol-MSM 
culture extract) revealed that these peaks contained both 
the protonated molecular species, as well as the sodi-
ated species of the surfactin group (Fig. 3). The ST34LC 
extract produced two major peaks at 11.0 and 11.7 min. 
The peak at 11.0  min corresponded to the lipopeptides 
in the Srf3 group which yielded a surfactin analogue with 
Mr of 1021.67 (expected Mr of 1021.67) and its sodium 
adduct at 1044.65 (expected Mr of 1044.65) (Fig.  3; 
Table 3). It was also observed that next to the main peak 
(11.0 min, Fig. 2b) obtained in the ST34 glycerol extract 
(ST34LC), were two peaks at 11.2 and 11.9  min that 
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Fig. 2 UPLC–MS profiles of surfactin standard (a), ST34 glycerol-MSM liquid culture (ST34LC) extract (b) and ST34 nutrient agar surface culture 
(ST34NA) (c) showing the five major surfactin groups. The top row profiles show the signal of positive molecular ions detected between 10 and 
13 min. Note the difference in Y axis which are a direct indication of amounts. The profiles below each top row spectrum show the extracted spectra 
of the five surfactin groups with Srf1 = m/z 994.6, Srf2 = m/z 1008.7; Srf3 = m/z 1022.7, Srf4 = m/z 1035.7 and Srf5 = m/z 1050.7
Page 9 of 19Ndlovu et al. AMB Expr  (2017) 7:108 
corresponded to the Srf2 (Fig.  2b; Table  3). The peaks 
at 11.2 and 11.9 min both corresponded to the surfactin 
analogues with Mr of 1007.65, which existed with their 
sodium adducts with Mr of 1030.64. The other major 
peak for the ST34LC extract was observed at 11.7  min 
and corresponded to the Srf3 group that showed an ana-
logue with Mr of 1021.67 (expected Mr of 1021.67) and 
its sodium adduct at 1044.65 (expected Mr of 1044.65) 
(Fig.  3; Table  3). A detailed analysis of the major peak 
observed for the ST34NA extract (NA = petri dish and 
test tube slant cultures; Fig.  2b) was then observed at 
12.1 min. The peak corresponded to the Srf4 group which 
yielded a surfactin analogue with Mr of 1035.68 (expected 
Mr of 1035.69) (Fig. 3; Table 3).
From the accurate Mr values and corresponding UPLC 
profiles it was then concluded that the ST34 extract con-
tained all five surfactin groups (Fig.  3; Table  3). After 
further comparison with all the commercial standards 
utilised in the current study (not shown), results showed 
that surfactin was the only lipopeptide biosurfactant 
detected in the ST34 extracts obtained from the glycerol-
MSM and NA using the production conditions (glycerol-
MSM, temperature and the agitation speed) applied in 
the current study.
The relative abundance of each surfactin group within 
the complex surfactin lipopeptides in the ST34 extract 
obtained from the glycerol-MSM and NA cultures was 
inferred from the Mr extracted chromatograms by com-
bining the peak areas of each surfactin group eluting 
between 10 and 13 min. The relative content for each sur-
factin group is illustrated in Additional file 1: Figure S1, 
and it showed that the Srf1 and Srf5 groups were below 
5% relative abundance in the ST34 extracts obtained 
from the glycerol-MSM and the NA media (both the 
test tube slant and petri dish cultures). The Srf2, Srf3 
and Srf4 were the main surfactin groups detected in the 
ST34 extracts illustrated in Additional file  1: Figure S1. 
The NA test tube slant culture produced the Srf4 group 
in higher concentrations, with a relative abundance of 
approximately 60% (Additional file 1: Figure S1). In con-
trast, the glycerol-MSM liquid cultures produced the Srf3 
in higher concentrations, with a relative abundance of 
approximately 43% (Additional file 1: Figure S1).
Direct ESI–MS analysis of solvent extracted biosurfactant 
compounds produced by ST5
Solvent extracts of the glycerol-MSM liquid culture 
obtained from ST5 were subjected to direct infusion 
using the positive ESI–MS in order to determine the 
accurate molecular mass (compound identity) for the 
solvent extracted biosurfactant compounds. The spectra 
of the possible biosurfactant compounds produced were 
compared to the rhamnolipid, surfactin, mycosubtilin, 
bacitracin, iturin A and fengycin standards. However, the 
compounds detected only corresponded to the profile 
observed for the rhamnolipid standard, hence only the 
results for rhamnolipid standard are depicted in Fig. 4. In 
the positive mode ESI–MS for the ST5 extract obtained 
from the glycerol-MSM ST5 culture we observed a series 
of sodiated singly charged ions at m/z values of 673.38, 
645.35, 527.32 and 499.29 (Fig. 4, Table 4). Correspond-
ing sodiated dimers [2  M−H+Na]+ at m/z, 1323.77, 
and 975.59 (Fig.  4) were also generally detected. For 
the standard rhamnolipid, the spectra in positive mode 
showed major molecular ions at m/z 651.40, 673.38 and 
mass
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1081.7535
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%
0
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%
0
100 1008.6619
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Fig. 3 Examples of the ESI–MS mass spectra of three major surfactin 
groups detected with UPLC–MS. The positive mass spectrum gener-
ated with MaxEnt 3 is shown. The indicated masses are [Mr+H] = m/z 
values of singly charged species. Refer to Table 3 for identities of 
Srf1-5 and expected m/z and Mr values
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1323.77, which corresponded to the singly charged spe-
cies, [M+H]+ and [M+Na]+, as well as sodiated dimer 
(Fig.  4). While analysing the full ion spectrum of the 
rhamnolipid standard, a series of ions of m/z values cor-
responding to the fragment or molecular ions of the 
3-(3-hydroxyalkanoyloxy) alkanoic acids (HAAs) were 
also observed (results not shown). These HAAs were 
also detected with the rhamnolipid congeners with m/z 
values of 331.2, 359.3 and 387.3, which correspond to 
protonated [M+H]+ molecular ions of a HAA contain-
ing one 3-hydroxydecanoate (C10) and one 3-hydroxyoc-
tanoate (C8) moiety, two C10 moieties and one C10 and 
one 3-hydroxydodecanoate (C12) moiety, respectively, 
were the most abundant (refer to discussion below and 
Fig. 6d).
The molecular mass of the possible rhamnolipid con-
geners detected in the ST5 extract were then determined 
from the molecular ions observed (Fig.  4; Table  4). The 
ST5 extract showed singly charged sodiated molecular 
species [M+Na]+ at m/z 645.35, 673.38, 701.41, 499.29, 
527.32, 555.35 (Fig. 4), which is in agreement with Mr of 
the dirhamnolipids Rha–Rha–C8–C10/Rha–Rha–C10–C8 
(dRL1), Rha–Rha–C10–C10 (dRL2), and Rha–Rha–C12–
C10/Rha–Rha–C10–C12 and monorhamnolipids, Rha–
C8–C10/Rha–C10–C8 (mRL1), Rha–C10–C10 (mRL2) 
and Rha–C10–C12/Rha–C12–C10 (mRL3), respectively 
(Table  4). Moreover, the m/z values at 331.25, 359.28 
and 387.32, which corresponded to protonated [M+H]+ 
molecular ions of a HAA containing C10–C8/C8–C10, 
C10–C10 and C10–C12/C12–C10 moieties, respectively 
mass
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Fig. 4 ESI–MS analysis of the ST5 glycerol-MSM extract (a) and rhamnolipid standard (b). The positive mass spectrum generated with MaxEnt 3 is 
shown. The indicated masses are [Mr+H] = m/z values of singly charged species. Refer to Table 4 for identities of RL 1-4 and expected m/z and Mr 
values
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were detected in the ST5 extract (refer to discussion 
below and Fig. 5).
ESI–MS and UPLC–MS analysis of solvent extracted 
biosurfactant compounds produced by ST5
As the chromatographic separation in UPLC–MS analy-
ses limits the interference of counter ions, it is more 
likely to detect more rhamnolipid species in both the 
rhamnolipid standard and ST5 culture extracts, as well 
as quantify these compounds. Our UPLC–MS method 
was therefore also used to analyse the glycolipid biosur-
factant extract obtained from ST5 cultured in glycerol-
MSM (ST5LC) (Fig. 4b). Surface cultures on NA in test 
tubes were also utilised to produce biosurfactants by 
ST5, in order to increase the probability of detecting 
glycolipids on different media (Fig.  4c). The chromato-
graphic profiles of the possible biosurfactant compounds 
produced were compared to the standards and analysis 
of results revealed that the profile obtained for ST5 only 
corresponded with the profile of the rhamnolipid stand-
ard (Fig. 4a). The comparative UPLC–MS profiles of the 
rhamnolipid standard and the extracts produced by ST5 
exhibited significant peaks at retention times between 6 
and 10.5 min. From basic reverse-phase chromatography 
principles, it is expected that the rhamnolipid species 
composed of two rhamnose and shorter HAA chain(s) 
will be eluted first, while the rhamnolipid with one rham-
nose sugar and longer HAA chain(s) will elute later from 
the C18 matrix. This principle was observed for the rham-
nolipid compounds produced by the ST5 strain, with the 
dirhamnolipids in the groups (dRL1, dRL2 and dRL3) 
eluting first and monorhamnolipid (mRL1, mRL2 and 
mRL3) eluting second in each group (Fig. 4a, b; Table 4).
For the glycerol-MSM culture extract, six peaks/peak 
clusters were observed in the UPLC–MS profile which 
corresponded to six rhamnolipid groups. The six rham-
nolipid groups from ST5 liquid culture extracts yielded 
identical retention times and m/z values (Fig. 4b) to those 
of the rhamnolipid standard (Fig.  4a). The ST5 extract 
obtained from the NA in a test tube (not shown) also 
displayed the same major peaks which corresponded to 
dirhamnolipids (dRL1, dRL2 and dRL3) and their monor-
hamnolipids (mRL1, mRL2 and mRL3) (Table 4).
A more detailed analysis of some of the major peaks 
in the UPLC–MS profiles revealed that these peaks con-
tained the free rhamnolipid congener, protonated and 
sodiated molecular species (Fig. 6). For example, the peak 
at 7.9  min corresponded to one of the glycolipid dRL2 
group that showed a rhamnolipid congener with Mr of 
650.39 (expected Mr of 650.39), the protonated ion at 
651.40 (expected m/z of 651.40) and its sodium adduct at 
m/z 673.38 (expected m/z of 673.38) (Fig. 6a). The peak 
at 8.7  min corresponded to the corresponding mRL2 
rhamnolipid congener with a Mr of 504.33 (expected Mr 
of 504.33), with its protonated species at m/z of 505.34 
(expected m/z of 505.34 Da) and its sodium adduct at m/z 
527.32 (expected m/z of 527.32) (Fig. 6b). The spectra for 
the monorhamnolipid mRL1 and its dirhamnolipid dRl1 
is shown in Fig.  6c and d. Furthermore, the protonated 
and sodiated HAA fragments of C10–C8/C8–C10, were 
also detected in the rhamnolipid mRL1 and dRL1 peaks 
(m/z 331.2 and 353.2) and HAA fragments of C10–C10 
in the mRL2 and dRL2 congener peaks (m/z 359.3 and 
381.3). Refer to Fig. 5d for the UPLC–MS profiles show-
ing the detection of these major HAAs with m/z values of 
331.2 and 359.3 in ST5LC extract.
Table 4 Summary of  the rhamnolipids extracted from  cultures of  P. aeruginosa ST5, as  detected with  high resolution 
mass spectrometry (<10 ppm)
Their proposed chemical structures, theoretical (Theor) and experimental (Exp) Mr and monoisotopic m/z values, as well as observed UPLC retention times for 
representative examples are provided
a  UPLC retention time of main peaks corresponding to the group’s m/z value
Rhamnolipid 
group (Abbr)
UPLC Rt (min)a Proposed struc‑
tures of rhamnolip‑
ids
Mono‑isotopic 
Exp/Theor Mr
Protonated specie 
Exp/Theor m/z
Sodiated specie 
Exp/Theor m/z
Sodiated dimeric 
specie Exp/Theor 
m/z
mRL1 7.23 Rha–C8–C10
Rha–C10–C8
476.3047
476.2985
477.3089
477.3063
499.2896
499.2883
975.5889
975.5868
dRL1 6.32
6.45
Rha–Rha–C8–C10
Rha–Rha–C10–C8
622.3576
622.3564
623.3654
623.3642
645.3471
645.3462
1267.7074
1267.7026
mRL2 8.77
8.84
Rha–C10–C10 504.3305
504.3298
505.3383
505.3376
527.3201
527.3196
1031.6501
1031.6494
dRL2 7.84
7.97
Rha–Rha–C10–C10 650.3894
650.3877
651.3972
651.3955
673.3772
673.3775
1323.7701
1323.7652
mRL3 10.32 Rha–C12–C10
Rha–C10–C12
532.3640
532.3611
533.3700
533.3689
555.3546
555.3509
1087.7201
1087.7120
dRL3 9.40
9.46
Rha–Rha–C12–C10
Rha–Rha–C10–C12
678.4177
678.4190
679.4285
679.4268
701.4114
701.4088
1379.8352
1379.8278
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Fig. 5 UPLC–MS profiles of rhamnolipid standard (a), ST5 glycerol-MSM liquid culture (ST5LC) extract (b) and ST5 nutrient agar surface culture 
(ST5NA) (c) showing the four major rhamnolipid groups. The top row profiles show the signal of positive molecular ions detected between 6 and 
10 min. The profiles below each top row spectrum show the extracted spectra of the five rhamnolipid groups with RL1 = m/z 673.4, RL2 = m/z 
645.3; RL3 = m/z 527.3 and RL4 = m/z 499.3. Profiles in d show the three types of HHAs (m/z 331.2, 359.3 and 387.3), either as precursors (third elut-
ing peak) or fragments (first two eluting peaks) found in the ST5LC extract
The peak at 10.3  min corresponded to the mRL3 
monorhamnolipid congener with a protonated molecu-
lar species at Mr 532.36 (expected Mr of 532.36), with 
its sodium adduct at m/z of 555.35 (expected 555.35). A 
dirhamnolipid Rha–Rha–C10–C12 or Rha–Rha–C12–C10 
was also produced and was observed at Rt 9.4 min at m/z 
701.41 (expected 701.41) (Fig. 5; Table 4). This identity of 
the lipid moiety was confirmed by the detection of the 
hydroxyl fragment of C10–C12/C12–C10 at m/z of 387.31 
in the RL3 congeners. Refer to Fig. 5d for the UPLC–MS 
profiles showing the detection of the C10–C12/C12–C10 
HAA ions with m/z at 387.3 in ST5LC extracts and the 
rhamnolipid standard.
Dimers of the sodiated [2  M−H+Na]+ dirhamnolipid 
Rha–Rha–C10–C10 (dRL2) and monorhamnolipid Rha–
C10–C10 (mRL2) were observed at m/z 1323.77 and 
1031.65, respectively (Table  4). Dimers of the sodiated 
[2  M−H+Na]+ dirhamnolipid Rha–Rha–C10–C8/Rha–
Rha–C8–C10 (dRL1) and monorhamnolipid Rha–C10–C8/
Rha–C8–C10 (mRL1) were observed at m/z 1267.71 and 
975.59, respectively. Similarly, the sodiated dimers of the 
RL3 group was also detected (Table 4).
The glycerol-MSM and NA cultures of ST5 lead to 
the production of similar rhamnolipid profiles (Fig.  5). 
A total of six rhamnolipid groups (mRL1-3 and dRL1-3) 
were identified in both the rhamnolipid standard and ST5 
culture extracts with high resolution ESI–MS (ppm < 10) 
and their proposed structures are presented in Table 4.
Antimicrobial activity of biosurfactant extracts
The antimicrobial activity of the identified surfactin 
and rhamnolipid extracts, produced by ST34 and ST5, 
respectively, were analysed against various actively grow-
ing reference (ATCC), environmental and clinical Gram-
positive and Gram-negative bacterial strains (Table  1) 
as well as fungal strains (Table 2). This was achieved by 
utilising an agar disc susceptibility modified method as 
outlined in Das et al. (2008). The zones of inhibition pro-
duced by each biosurfactant extract against each micro-
bial strain used as a test organism, were recorded.
Antimicrobial activity of ST34 extract
The extracts of strain ST34 were tested against Gram-
negative reference (ATCC) strains (n  =  10), as well as 
environmental (n = 8) and clinical (n = 2) strains. Over-
all, antibacterial activity was observed against all the 
Gram-negative bacteria (100%) analysed as test organ-
isms (Table  1), with varying diameters for the zones of 
inhibition recorded. For the ten Gram-negative reference 
strains, the ST34 extracts displayed the lowest zone of 
inhibition of 10 mm against E. coli ATCC 13706 and the 
highest zone of inhibition against Salmonella typhimu-
rium ATCC 14028 at 25.3 ± 1.2 mm (Table 1). An aver-
age zone of inhibition of 15.2 ± 0.6 mm was observed for 
the reference strains. The ST34 extract was also tested 
against environmental strains (Table  1), with the small-
est zone of inhibition (9.8 ±  0.8  mm) observed against 
the Serratia sp. L8 strain and the largest zone of inhibi-
tion (17.7 ± 1.9 mm) observed against the E. coli K4CCA 
strain. An average zone of inhibition of 13 ± 0.6 mm was 
observed for all environmental strains. Furthermore, the 
ST34 extracts displayed zones of inhibition of 13 ±  0.8 
and 13.3 ±  0.2 mm against the two clinical K. pneumo-
niae strains (P2 and P3), respectively. It should be noted 
that while the antimicrobial assays were conducted 
against the test bacterial strains utilising the 15% metha-
nol surfactin (crude extract) extract, the antimicrobial 
assays conducted utilising the 70% acetonitrile surfac-
tin extract against E. coli ATCC 13706 produced similar 
results. The antimicrobial activity (12.5 ± 0.9 mm) of the 
15% methanol surfactin and the 70% acetonitrile surfac-
tin extract against E. coli ATCC 13706 were thus compa-
rable. The antibacterial activity of the commercial pure 
surfactin against E. coli ATCC 13706 (12.7  ±  1.2  mm) 
was also comparable to the antibacterial activity of both 
surfactin extracts (15% methanol and 70% acetonitrile 
extracts) obtained from B. amyloliquefaciens ST34.
The ST34 extract was then tested against Gram-pos-
itive reference strains (n =  3), as well as environmental 
(n = 5) and clinical (n = 3) strains. Overall, antibacterial 
activity was observed against 90.1% of the Gram-positive 
bacteria analysed as test organisms (Table 1), with vary-
ing diameters for the zones of inhibition recorded. All the 
reference strains displayed sensitivity against the extract 
produced by ST34, where the smallest zone of inhibi-
tion (10.3 ±  0.5 mm) was observed for B. cereus ATCC 
10876 and the largest zone of inhibition (14.7 ± 0.5 mm) 
was observed for Staphylococcus aureus ATCC 25923. 
An average zone of inhibition of 12.7  ±  0.6  mm was 
observed for the reference strains. For the five environ-
mental strains utilised, the surfactin extract displayed 
no zone of inhibition against B. cereus ST18, while the 
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largest zone of inhibition (14 mm) was obtained against 
Micrococcus sp. AQ4S2. An average zone of inhibition 
against environmental Gram-positive bacterial strains 
was observed at 10 ± 0.2 mm. The ST34 extract was also 
tested against the clinical strains, which displayed the 
smallest zone of inhibition of 15.3 ±  0.5  mm against S. 
aureus (MRSA) Xen 30, while the largest zone of inhibi-
tion was observed at 18.7 ±  0.9  mm against E. faecalis 
S2. An average zone of inhibition of 17.4 ± 0.9 mm was 
observed for the clinical strains. The antibacterial activity 
of the commercial pure surfactin against S. aureus ATCC 
25923 (17.8 ± 0.8 mm) was also comparable to the crude 
surfactin extract obtained from B. amyloliquefaciens 
ST34.
Five clinical and five environmental fungal strains were 
utilised as test organisms for the antimicrobial assess-
ment of solvent extracted from ST34 (Table  2). The 
ST34 extract exhibited pronounced antifungal activ-
ity against 80% (4/5) of the clinical strains tested. No 
antifungal activity was observed against Cryptococcus 
neoformans 1063, while the largest zone of inhibi-
tion of 15.3  ±  0.5  mm was observed for C. neofor-
mans CAB1055. An average zone of inhibition of 
10.7 ± 0.4 mm was observed for the clinical strains. The 
ST34 extract also displayed antifungal activity against 
60% (3/5) of the environmental fungal isolates utilised 
in the current study. No zone of inhibition was observed 
for C. neoformans CAB1034 and Candida albicans 1085 
and the largest zone of inhibition of 15.3 ± 1.2 mm was 
observed for the Cryptococcus neoformans CAB844 
environmental strain. An average zone of inhibition of 
7.9 ±  0.8 mm was observed for the environmental fun-
gal strains. In addition, the antifungal activity of the com-
mercial pure surfactin against C. neoformans CAB1055 
(13.7 ± 1.2 mm) was comparable to the surfactin extract 
obtained from B. amyloliquefaciens ST34.
Antimicrobial activity of ST5 extract
The extract of strain ST5 was tested against the Gram-
negative reference (ATCC) (n  =  10), environmental 
Fig. 6 Examples of the ESI–MS mass spectra of major rhamnolipid groups detected with UPLC–MS (dRL1-2 and mRL1-2). Mass spectra were gener-
ated with MaxEnt 3. Refer to Table 4 for identities of dRL1-2 and mRL1-2 and expected m/z and Mr values
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(n = 8) and clinical (n = 2) strains. Overall, antibacterial 
activity was observed against all the Gram-negative bac-
terial (100%) strains analysed as test organisms (Table 1), 
with varying diameters for the zones of inhibition 
recorded. For the reference strains, the ST5 extract dis-
played the smallest zone of inhibition (13  mm) against 
Enterotoxigenic E. coli H10407, while the largest zone 
of inhibition (29.3  ±  0.9  mm) was observed against 
E. coli ATCC 13706. An average zone of inhibition of 
18.5 ± 0.7 mm was obtained against the reference strains. 
For the environmental strains, the ST5 extract produced 
the smallest zone of inhibition of 9.8 ±  0.8  mm against 
the Serratia sp. L8 strain, while the largest zone of inhi-
bition of 17.7  ±  1.9  mm was recorded against E. coli 
K4CCA. The average zone of inhibition against the envi-
ronmental strains was 13.6 ± 0.9 mm. Furthermore, the 
ST5 extracts displayed zones of inhibition of 8.3  ±  0.5 
and 11.7 ±  0.9 mm against the two clinical K. pneumo-
niae strains (P2 and P3), respectively. For the antimicro-
bial assays conducted against E. coli ATCC 13706 utilising 
the 15% methanol rhamnolipid (crude extract) extract 
and the 70% acetonitrile rhamnolipid extract, a decreased 
antimicrobial activity was observed for the 70% acetoni-
trile rhamnolipid extract (15.3 ± 1.5 mm) in comparison 
to the crude extract. In addition, the antibacterial activity 
of the commercial pure rhamnolipid against E. coli ATCC 
13706 (13.3 ± 1.2 mm) was lower in comparison to both 
rhamnolipid extracts (15% methanol and 70% acetonitrile 
extracts) obtained from P. aeruginosa ST5.
The ST5 extract was also tested against Gram-posi-
tive reference (n = 3), environmental (n = 5) and clini-
cal (n  =  3) strains. Overall, antibacterial activity was 
observed against all the Gram-positive bacterial (100%) 
strains analysed as test organisms (Table  1), with vary-
ing diameters for the zones of inhibition recorded. For 
the reference strains, the smallest zone of inhibition of 
13.0 ± 0.8 mm was recorded for B. cereus ATCC 10876, 
while the largest zone of inhibition of 17 ± 1.4 mm was 
recorded for B. cereus LMG 13569. An average zone of 
inhibition of 14.6 ± 0.9 mm was obtained. For the Gram-
positive environmental strains, the smallest zone of inhi-
bition of 11 mm was recorded for S. aureus C3, while the 
largest zone of inhibition (22.3 ± 0.9 mm) was observed 
against B. cereus ST18. An average zone of inhibition of 
15.4 ±  0.9 mm was obtained against the environmental 
Gram-positive strains. The ST5 extract also displayed 
activity against all clinical strains, with the smallest zone 
of inhibition of 10.7 ±  0.5  mm recorded for E. faecalis 
S1 and the largest zone of inhibition of 21.7 ±  2.4  mm 
recorded for E. faecalis S2. The average zone of inhibition 
produced by the ST5 extract against the clinical strains 
was 15.2 ± 1.1 mm. The antibacterial activity of the com-
mercial pure rhamnolipid against S. aureus ATCC 25923 
(13.3 ± 1.2 mm) was then comparable to the antibacterial 
activity of the rhamnolipid extract obtained from P. aer-
uginosa ST5.
Five clinical and five environmental fungal strains 
were utilised as test organisms for the antimicrobial 
assessment of solvent extracted compounds from ST5 
(Table  2). The ST5 extract displayed antifungal activ-
ity against 100% (5/5) of the clinical strains tested. 
The smallest zone of inhibition of 11.3  ±  0.9  mm was 
observed for C. neoformans CAB 1055 and the largest 
zone of inhibition (14.7 ± 0.5 mm) was obtained against 
C. albicans 8911 strain. An average zone of inhibition by 
the ST5 extract against the clinical strains was recorded 
as 13  ±  1.2  mm. The ST5 extract then displayed 80% 
(4/5) antifungal activity against the environmental fun-
gal strains. No zone of inhibition was observed against 
C. neoformans CAB842, and the largest zone of inhibi-
tion (18 ± 0.8 mm) was observed against C. neoformans 
1034. An average zone of inhibition of 12 ±  1  mm was 
observed for the ST5 extract against the environmental 
fungal strains. The antifungal activity of the commer-
cial pure rhamnolipid against C. neoformans CAB1055 
(12.7 ± 1.2 mm) was comparable to the antifungal activ-
ity of the rhamnolipid extracts obtained from P. aerugi-
nosa ST5.
Discussion
Bacteria, fungi and yeast producing biosurfactant com-
pounds, which display broad spectrum antimicrobial 
properties, are usually isolated from diverse terrestrial 
environments such as the rhizosphere, contaminated 
soils and hydrocarbon polluted water sources (Bento 
et al. 2005; Pornsunthorntawee et al. 2008). Initial analy-
sis then indicated that the two bacterial strains ST34 (B. 
amyloliquefaciens) and ST5 (P. aeruginosa) isolated from 
wastewater, produced biosurfactants (Ndlovu et al. 2016). 
The current study thus focused on the partial purifica-
tion and characterisation of the antimicrobial lipopeptide 
and glycolipid biosurfactant compounds produced by 
ST34 and ST5, respectively. The extracts obtained from 
the ST34 and ST5 cultures were characterised using a 
method that was developed in the current study for use 
with the UPLC–MS analysis, which facilitated the suc-
cessful detection and separation of different analogues of 
the surfactin (ST34) and rhamnolipids (ST5) produced by 
the respective strains.
The solvent extracts obtained from the B. amylolique-
faciens (ST34) strain were confirmed to contain surfactin 
lipopeptides, in which the structural surfactin analogues 
with a mass difference of 14 or 28 amu. These differences 
are consistent with a CH2 moiety correlating either to a 
Val to IIe/Leu modification or longer/branched fatty acyl 
chain (CH2–CH2 moiety). The UPLC–MS separation 
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successfully differentiated between the surfactin ana-
logues in the same mixture, which were identified as 
C13, C14, C15 and C16 surfactin analogues (Srf1-5 groups) 
(Table 3). The different groups were observed to have two 
or more retention times even though they displayed the 
same m/z and Mr values. The lle containing peptides pos-
sibly elute at a slightly different Rt to those substituted 
with Leu due to the slight differences in their hydropho-
bicity (Yang et al. 2015), for example Srf4 eluted at 12.1 
and 12.2 min (Table 3). Within each of the five surfactin 
groups obtained for the ST34 strain, two or more surfac-
tin analogues were detected. The Srf4 group was the most 
dominant with a relative abundance of approximately 
60% in the ST34 NA culture extracts, while the Srf3 
and Srf4 groups were observed at approximately 43 and 
33%, respectively, in the glycerol-MSM culture extracts. 
Results obtained in the current study are comparable to 
a study conducted by Pecci et al. (2010), were they suc-
cessfully identified different surfactin (C13 (Srf1-2), C14 
(Srf2-3) and C15 (Srf4) surfactins), fengycin A and B ana-
logues compounds produced by Bacillus licheniformis 
V9T14. The authors utilised the LC–ESI–MS/MS for the 
separation and partial characterisation of the surfactin 
analogues and fengycin isoforms, as well as the relative 
percentage content of each compound.
The solvent extracts obtained from the ST5 strain were 
confirmed to be a mixture of rhamnolipid congeners of 
monorhamnolipids (Rha–C12–C10/Rha–C10–C12; Rha–
C10–C10; Rha–C10–C8/Rha–C10–C8) and dirhamnolipids 
(Rha–Rha–C12–C10/RhaRha–C10–C12; Rha–Rha–C10–
C10; Rha–Rha–C10–C8/Rha–Rha–C10–C8). These results 
are in agreement with a study conducted by Pantazaki 
et al. (2011), where similar rhamnolipid congeners were 
detected. Additionally, the detected HAAs in the current 
study could either be intermediates in rhamnolipid bio-
synthesis or rhamnolipid fragments obtained by cleavage 
in the ESI–MS of the rhamnosyl group (hydrophilic moi-
ety) (Lépine et  al. 2002). A study conducted by Pereira 
et al. (2012) on rhamnolipids produced by P. aeruginosa 
strains also illustrated that MS coupled with electro-
spray ionisation provided an accurate and rapid char-
acterisation of the monorhamnolipids [Rha–C10–C10, 
Rha–C10–C12, Rha–C10–C12:1] and dirhamnolipids [Rha–
Rha–C10–C10, Rha–Rha–C10–C12]. Itoh et al. (1971) then 
produced a mixture of monorhamnolipid (Rha–C10–C10) 
and dirhamnolipid (Rha–Rha–C10–C10) congeners using 
the P.  aeruginosa KY 4025 strain, which they purified 
and separated using the HPLC based method to obtain 
individual rhamnolipids. Moreover, they showed that 
individual rhamnolipids (Rha–C10–C10 and Rha–Rha–
C10–C10) displayed pronounced antibacterial activity 
against both Gram-negative and Gram-positive strains, 
including a multi-drug resistant E. coli strain.
The antimicrobial activity of the extracts containing 
surfactin and rhamnolipid congeners produced by ST34 
and ST5 against various reference, environmental and 
clinical bacterial and fungal strains was then determined. 
Results indicated that both extracts displayed 100% anti-
bacterial activity against the Gram-negative bacteria 
analysed (Table 1). However, based on the average zones 
of inhibition, the surfactin extract (ST34) exhibited an 
increased antibacterial activity against the clinical strains 
(average zone of inhibition of 13.2 ± 0.5 mm), while the 
rhamnolipid extract (ST5) produced noticeable activ-
ity (average zone of inhibition of 18.5 ± 0.7 mm) against 
the reference target strains. No significant difference 
between the surfactin and rhamnolipid extract’s antibac-
terial activity against the Gram-negative environmen-
tal (p = 0.58) and reference (p = 0.17) bacterial strains, 
respectively, was however observed. In addition, the 
surfactin extract displayed a higher antibacterial activ-
ity against the Gram-positive clinical strains (average 
zone of inhibition 17.4 ± 0.9 mm), while the rhamnolipid 
extracts produced an increased antibacterial activity 
against the Gram-positive environmental (average zone 
of inhibition 15.4 ± 0.5 mm) and reference strains (aver-
age zone of inhibition 14.6 ± 0.9 mm). However, the two 
tailed t-test showed that there was no significant differ-
ence between the zones of inhibition obtained against the 
clinical (p = 0.56) and environmental (p = 0.12) Gram-
positive strains, respectively for the surfactin and rham-
nolipid extracts. Moreover, the surfactin and rhamnolipid 
extracts displayed no significant difference (p  =  0.34) 
between the zones of inhibition obtained against the ref-
erence Gram-positive strains. Of particular interest was 
the sizeable zone of inhibition (22.3 ± 0.9 mm) recorded 
for the rhamnolipid extract against the B. cereus ST18, 
which was seemingly resistant to the surfactin extract as 
no zone of inhibition was recorded.
Research has indicated that approximately 5% of the 
genome of most Bacillus species encodes for the synthesis 
of antimicrobial compounds (Stein 2005). Of these struc-
turally diverse antimicrobial compounds, approximately 
two dozen have been characterised, with the cyclic lipo-
peptides of three families fengycin, iturin and surfactin 
displaying antifungal and antibacterial properties (Mandal 
et  al. 2013). Surfactin exhibits an antimicrobial mecha-
nism by accumulating on the surface of the microbial cell 
(bacteria and fungi) until a threshold concentration is 
reached. Thereafter they permeate the membrane lead-
ing to its disintegration by a detergent-like mechanism 
(Yao et  al. 2012). This disintegration is hypothesised to 
occur by the formation of pores in the cell membrane of 
microbial cells thus inducing an increased influx of Ca2+ 
and H+ into the cells (Thrane et al. 1999). Comparatively, 
rhamnolipids have structures and properties similar to 
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that of detergents and have been reported to intercalate 
into the membrane phospholipid bilayer thereby facilitat-
ing the permeability of the membrane and flow of metab-
olites (Sotirova et al. 2008). The structure and function of 
the phospholipid bilayer is thus altered, effectively inter-
rupting protein conformation, transport and energy gen-
eration, which eventually leads to cell death.
It should be noted that of the 31 bacterial strains ana-
lysed in the current study, three strains were resistant to 
various classes of antibiotics [Enteropathogenic E. coli 
B170 resistant to gentamicin, S. aureus ATCC 25923 
resistant to oxacillin, S. aureus Xen 30 resistant to methi-
cillin, gentamicin, oxacillin and tetracycline (Table  1)]. 
The results obtained in the current study indicated that 
these strains were sensitive to both the surfactin and 
rhamnolipid extracts produced by ST34 and ST5, respec-
tively. Moreover, 90% of the fungal strains analysed in 
the current study were susceptible to the rhamnolipid 
extract, while only 70% of the fungal strains were suscep-
tible to the surfactin extract. Although, after perform-
ing a two-tailed t-test analysis, no significant difference 
(p =  0.183) between the zone of inhibition of surfactin 
and rhamnolipid extracts against the fungal strains ana-
lysed was obtained. Yoshida et  al. (2001), then showed 
that the cell free supernatant (containing surfactin) of B. 
amyloliquefaciens RC-2, isolated from healthy Mulberry 
leaves, strongly inhibited the growth of 44 and 40% of 
bacteria and fungi isolates, respectively. In a study con-
ducted by Sun et al. (2006), a B. amyloliquefaciens ES-2 
isolate was also shown to produce antimicrobial lipo-
peptide compounds (fengycins and surfactins), which 
demonstrated antimicrobial activity against a total of 
37 microorganisms (including E. coli, S. aureus and B. 
cereus). In a study conducted by Abalos et  al. (2001), a 
rhamnolipid mixture that consisted of Rha–C10–C10, 
Rha–C10–C12, Rha–Rha–C10–C10, Rha–Rha–C10–C12, 
then displayed broad spectrum antimicrobial activity 
against a wide range of organisms, including C. albicans, 
S. marcescens, B. cereus and S. aureus strains. However, 
in a previous study conducted by Liu et al. (2012), it was 
demonstrated that the surfactin C15 analogue together 
with ketoconazole (a synthetic antifungal compound) 
exhibited effective synergistic antifungal activity against 
C. albicans SC5314 at concentrations of  >6.25 and 
0.004  µg  mL−1, respectively. These concentrations were 
lower than the individual antifungal activity observed 
at >100 µg mL−1 (surfactin C15) and 0.016 µg mL−1 (keto-
conazole) (Liu et al. 2012). Future studies on the possible 
synergistic effects of other compounds on the antimi-
crobial activity of the surfactin and rhamnolipid extracts 
produced by ST34 and ST5 strains, respectively, will thus 
be highly beneficial to elucidate the role of each com-
pound in the observed antimicrobial activity.
In the current study, the optimised UPLC–MS method 
was successfully employed to characterise the extracted 
surfactin and rhamnolipid mixtures produced by the B. 
amyloliquefaciens ST34 and P. aeruginosa ST5 isolates 
in liquid and on agar media. The B. amyloliquefaciens 
ST34 strain produced a mixture of surfactin analogues 
(Srf1-5), which have a synergistic effect on inhibiting bac-
terial and fungal growth. The most abundant surfactin 
groups were Srf4 > Srf3 > Srf2 with minor contributions 
by Srf1 and Srf5. The Rha–C10–C10 and Rha–C10–C8 or 
Rha–C10–C8 were the most abundant monorhamnolipids 
in the extracts, while the Rha–Rha–C10–C10 and Rha–
Rha–C10–C8 or Rha–Rha–C10–C8 were the most abun-
dant dirhamnolipids produced by the P. aeruginosa ST5 
strain. In this context, the results indicate that our rapid 
extraction and UPLC–MS method can be a simple and 
powerful technique to provide fast, sensitive and accu-
rate identification of a variety biosurfactant compounds 
synthesised by microbial strains. In addition, pronounced 
antimicrobial activity against diverse microorganisms, 
including antibiotic resistant S. aureus and E. coli, as 
well as the fungal pathogens C. albicans and C. neofor-
mans was retained by both the surfactin and rhamnolipid 
extracts. The two biosurfactant producing strains iso-
lated from wastewater thus show potential for large-scale 
production of various analogues/congeners of the surfac-
tin and rhamnolipid biosurfactant compounds for utilisa-
tion in the medical and food industries as antimicrobial 
agents.
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